Henry Schein, Inc. NMS · HSIC
Price alert —
Sign in to get a one-time email the moment HSIC crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · HSIC
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.4B | $0.1B | $0.2B | $-0.1B | 3.2% | 5.8% |
| 2025-12-31 | $3.4B | $0.1B | $0.2B | $0.3B | 2.9% | 5.4% |
| 2025-09-30 | $3.3B | $0.1B | $0.2B | $0.1B | 3.0% | 5.9% |
| 2025-06-30 | $3.2B | $0.1B | $0.2B | $0.1B | 2.7% | 5.4% |
| 2025-03-31 | $3.2B | $0.1B | $0.2B | $-0.0B | 3.5% | 6.3% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare HSIC vs peers
Line HSIC up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with HSIC
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-05 | 1.32 | 1.22 | +8.4% | -2.6% |
| 2026-02-24 | 1.34 | 1.29 | +3.5% | -1.7% |
| 2025-11-04 | 1.38 | 1.28 | +7.9% | +0.6% |
| 2025-08-05 | 1.10 | 1.19 | -7.6% | +2.3% |
| 2025-05-05 | 1.15 | 1.11 | +3.6% | -0.5% |
| 2025-02-25 | 1.19 | 1.21 | -1.6% | -4.3% |
| 2024-11-05 | 1.22 | 1.17 | +4.5% | +1.5% |
| 2024-08-06 | 1.23 | 1.22 | +1.0% | +2.9% |
| 2024-05-07 | 1.10 | 1.01 | +8.6% | +2.2% |
| 2024-02-27 | 0.66 | 0.70 | -5.2% | -1.8% |
| 2023-11-13 | 1.32 | 1.32 | +0.2% | +2.1% |
| 2023-08-07 | 1.31 | 1.28 | +2.6% | +0.1% |
| 2023-05-09 | 1.21 | 1.23 | -1.9% | +1.9% |
| 2023-02-16 | 1.35 | 1.22 | +10.7% | +0.4% |
| 2022-11-01 | 1.15 | 1.14 | +1.3% | -2.9% |
| 2022-08-02 | 1.16 | 1.16 | -0.1% | -1.3% |
| 2022-05-03 | 1.30 | 1.19 | +9.4% | +5.3% |
| 2022-02-15 | 1.07 | 0.91 | +17.1% | +2.9% |
| 2021-11-02 | 1.10 | 0.96 | +14.8% | +0.9% |
| 2021-08-03 | 1.11 | 0.98 | +13.7% | -3.8% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| HSIC ★ | $10B | 26.5 | 14.9 | 0.7 | 14.5 | 3.1 | 31.2% | 6.3% | 4.5% | 2.90% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 55.32%
| Holder | Shares | % out |
|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | 15,652,032 | 13.74% |
| Blackrock Inc. | 7,022,989 | 6.17% |
| Artisan Partners Limited Partnership | 6,573,023 | 5.77% |
| Vanguard Capital Management LLC | 6,423,167 | 5.64% |
| FMR, LLC | 5,722,149 | 5.02% |
| Invesco Ltd. | 4,886,483 | 4.29% |
| JPMORGAN CHASE & CO | 4,562,512 | 4.01% |
| State Street Corporation | 4,378,981 | 3.84% |
| Vanguard Portfolio Management LLC | 4,194,920 | 3.68% |
| American Century Companies Inc | 3,594,359 | 3.16% |
Insider activity · 90d
2 buys / 0 sells · ratio 2.0 · Finnhub
- DANIEL WILLIAM K BUY 7,641
- BERGMAN STANLEY M G 253,279
- BERGMAN STANLEY M G 253,279
- BERGMAN STANLEY M G 253,329
- DANIEL WILLIAM K BUY 20,000 @ $69.19
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-15 | 4 | view · |
| 4 | 2026-05-22 | 4 | view · |
| 8-K | 2026-05-22 | 8-K | view · |
| 4 | 2026-05-21 | 4 | view · |
| 4 | 2026-05-12 | 4 | view · |
| 10-Q | 2026-05-05 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) | view · |
| 8-K | 2026-05-05 | CURRENT REPORT FILING | view · |
| DEF 14A | 2026-04-08 | DEF 14A | view · |
| 4 | 2026-03-20 | 4 | view · |
| 4 | 2026-03-17 | 4 | view · |
| 4 | 2026-03-17 | 4 | view · |
| 4 | 2026-03-17 | 4 | view · |
| 4 | 2026-03-17 | 4 | view · |
| 4 | 2026-03-17 | 4 | view · |
| 4 | 2026-03-17 | 4 | view · |
| 4 | 2026-03-17 | 4 | view · |
| 4 | 2026-03-16 | 4 | view · |
| 4 | 2026-03-11 | 4 | view · |
| 4 | 2026-03-10 | FORM 4 | view · |
| 4 | 2026-03-10 | FORM 4 | view · |
| 4 | 2026-03-10 | 4 | view · |
| 4 | 2026-03-10 | 4 | view · |
| 4 | 2026-03-10 | 4 | view · |
| 4 | 2026-03-10 | 4 | view · |
| 4 | 2026-03-10 | 4 | view · |
| 4 | 2026-03-10 | 4 | view · |
| 4 | 2026-03-10 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-09 | 4 | view · |
| 4 | 2026-03-06 | 4 | view · |
| 4 | 2026-03-06 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-03-03 | 4 | view · |
| 4 | 2026-02-27 | 4 | view · |
| 10-K | 2026-02-24 | THE 2025 ANNUAL 10-K REPORT | view · |
| 8-K | 2026-02-24 | HENRY SCHEIN 4Q 2025 QUARTERLY 8-K | view · |
| 8-K | 2026-01-12 | 8-K | view · |
| 8-K | 2025-12-23 | 8-K | view · |
| 8-K | 2025-12-23 | 8-K | view · |
| 4 | 2025-12-11 | 4 | view · |
| 4 | 2025-12-09 | FORM 4 | view · |
| 4 | 2025-12-09 | FORM 4 | view · |
| 8-K | 2025-12-09 | 8-K | view · |
About HSIC
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related produc…
Options picks · HSIC
ITM + OTM ideas from the latest scanLoading…
Congress trades · HSIC
STOCK Act disclosuresLoading…
SEC filings & insiders · HSIC
EDGAR · liveLoading…
Holders · HSIC
Institutions & insider activityLoading…